We are excited to announce that Seda’s continued growth through 2020 and into 2021 has led to the recent addition of four new appointments joining the team.

Alan Raoof joins as Pharmaceutical Scientist with strong analytical experience from working in a GMP environment and academia. With 2 MSc degrees in Drug Design and Discovery plus Pharmaceutical Analysis, Alan brings with him a range of knowledge and expertise.

Kati de Matas joins as Business Administrator to support with the day to day running of the business, including procurement and marketing. Kati brings with her experience in digital marketing and a first-class honours degree in Mathematics from Keele University.

 

Alex Clout joins as Senior Scientist with experience in nanomedicine, formulation development, and solid-state characterisation. Alex has a background in chemistry and holds a PhD in pharmaceutics from University College London, during which he gained extensive experience in the solid-state characterisation of pharmaceutical materials, including polymorphism and co-crystallisation, combining both thermal and structural analyses to develop a full picture of the changes occurring when materials undergo phase transitions. More recently he has worked on projects in formulation development with a particular focus on the microfluidic manufacture of nanomaterials for administration of sustained release parenterals. He also has valuable experience in the development and manufacture of oral solid dosage forms.

 

Parmesh Gajjar joins as Principal Scientist with a strong mathematical background from multiple high-rank academic institutions, coupled with experience working alongside the pharmaceutical industry to understand inhaled medicine therapies. Parmesh will join the modelling team to support our PKPD modelling services.

 

Please join us in celebrating these new appointments, and welcome Alan, Kati, Alex and Parmesh to the Seda team.